Bacterial Strain Type and Biomarkers Predict Mortality
|
By LabMedica International staff writers Posted on 08 Aug 2013 |
|
Image: Clostridium difficile colonies grown on cycloserine mannitol agar (Photo courtesy of Janice Carr).
Clostridium difficile genotype predicts mortality after C. difficile infection (CDI), and excess mortality correlates with genotype-specific changes in biomarkers.
The relationship between the specific bacterial strain types with changes in the host’s biomarkers strongly implicates inflammatory pathways as a factor in poor outcomes after CDI.
Scientists at the John Radcliffe Hospital (Oxford, UK) used multilocus sequence typing (MSLT) on strains isolated from C. difficile toxin enzyme immunoassay (EIA)-positive fecal samples from September 2006 to May 2011. The study involved 2,745 toxin-positive and 27,550 toxin-negative strains. The C. difficile toxin enzyme immunoassay used was from Meridian Bioscience (Cincinnati, OH, USA).
Overall, 14-day mortality was 13% in patients with EIA-positive samples versus 5% with EIA-negative samples. Strain polymerase chain reaction (PCR) ribotype 078/ST 11 was associated with the highest mortality at 25%, followed by PCR ribotype 27/ST 1 at 20%. Across a variety of blood or serum markers, the authors also found a significant variance in mean baseline neutrophil counts by genotype, and EIA-positivity versus EIA-negativity. Overall, biomarkers predicted 30% to 40% of strain-specific mortality differences.
Threshold levels of serum albumin equal to or less than 24.5 g/L, C- reactive protein (CRP) greater than 228 mg/L, white cell count (WBC) greater than 12 × 103 /µL, and increased respiratory rates were associated with an increased risk of all-cause mortality. A simple four variable prediction rule was devised based on these threshold levels and when tested on the initial data.
The authors concluded that MLST demonstrates that strain predicts mortality and severity biomarkers at both clade and individual sequence-type level. For patient monitoring, neutrophils/WBC ratios, CRP, and albumin are the key as C. difficile–associated biomarkers that are highly prognostic for short-term mortality. The study was published in the August 15, 2013, edition of the journal Clinical Infectious Diseases.
Related Links:
John Radcliffe Hospital
Meridian Bioscience
.jpg)
The relationship between the specific bacterial strain types with changes in the host’s biomarkers strongly implicates inflammatory pathways as a factor in poor outcomes after CDI.
Scientists at the John Radcliffe Hospital (Oxford, UK) used multilocus sequence typing (MSLT) on strains isolated from C. difficile toxin enzyme immunoassay (EIA)-positive fecal samples from September 2006 to May 2011. The study involved 2,745 toxin-positive and 27,550 toxin-negative strains. The C. difficile toxin enzyme immunoassay used was from Meridian Bioscience (Cincinnati, OH, USA).
Overall, 14-day mortality was 13% in patients with EIA-positive samples versus 5% with EIA-negative samples. Strain polymerase chain reaction (PCR) ribotype 078/ST 11 was associated with the highest mortality at 25%, followed by PCR ribotype 27/ST 1 at 20%. Across a variety of blood or serum markers, the authors also found a significant variance in mean baseline neutrophil counts by genotype, and EIA-positivity versus EIA-negativity. Overall, biomarkers predicted 30% to 40% of strain-specific mortality differences.
Threshold levels of serum albumin equal to or less than 24.5 g/L, C- reactive protein (CRP) greater than 228 mg/L, white cell count (WBC) greater than 12 × 103 /µL, and increased respiratory rates were associated with an increased risk of all-cause mortality. A simple four variable prediction rule was devised based on these threshold levels and when tested on the initial data.
The authors concluded that MLST demonstrates that strain predicts mortality and severity biomarkers at both clade and individual sequence-type level. For patient monitoring, neutrophils/WBC ratios, CRP, and albumin are the key as C. difficile–associated biomarkers that are highly prognostic for short-term mortality. The study was published in the August 15, 2013, edition of the journal Clinical Infectious Diseases.
Related Links:
John Radcliffe Hospital
Meridian Bioscience
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
Latest Microbiology News
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
- Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions
- Culture-Free Platform Rapidly Identifies Blood Stream Infections
- POC PCR Test Rapidly Detects Bacterial Meningitis Directly at Point of Sample Collection
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
Molecular Diagnostics
view channel
Novel Point-of-Care Technology Delivers Accurate HIV Results in Minutes
HIV diagnostic methods have traditionally relied on detecting HIV-specific antibodies, which typically appear weeks after infection. This delayed detection has hindered early diagnosis, complicating patient... Read more
Blood Test Rules Out Future Dementia Risk
Previous studies have suggested that specific biomarkers, such as tau217, Neurofilament Light (NfL), and Glial Fibrillary Acidic Protein (GFAP), may be valuable for early dementia diagnosis.... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Pathology
view channel
AI Model Predicts Patient Response to Bladder Cancer Treatment
Each year in the United States, around 81,000 new cases of bladder cancer are diagnosed, leading to approximately 17,000 deaths annually. Muscle-invasive bladder cancer (MIBC) is a severe form of bladder... Read more
New Laser-Based Method to Accelerate Cancer Diagnosis
Researchers have developed a method to improve cancer diagnostics and other diseases. Collagen, a key structural protein, plays various roles in cell activity. A novel multidisciplinary study published... Read more
New AI Model Predicts Gene Variants’ Effects on Specific Diseases
In recent years, artificial intelligence (AI) has greatly enhanced our ability to identify a vast number of genetic variants in increasingly larger populations. However, up to half of these variants are... Read more
Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read moreTechnology
view channel
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read moreIndustry
view channel
New Collaboration to Advance Microbial Identification for Infectious Disease Diagnostics
With the rise of global pandemics, antimicrobial resistance, and emerging pathogens, healthcare systems worldwide are increasingly dependent on advanced diagnostic tools to guide clinical decisions.... Read more
